Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qi Mei

Showing results (171-180 of 249) with videos related to

Pageof 25
Sort By:
Journal for Immunotherapy of Cancer|March 10, 2022
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world studyQi Mei, Guangyuan Hu, Yang Yang, et al.
Frontiers in Cell and Developmental Biology|July 21, 2022
Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach AdenocarcinomaNa Luo, Min Fu, Yiling Zhang, et al.
Fitoterapia|October 17, 2025
Five new lanostane-type triterpenoids from Poria cocos and their in vitro anti-asthmatic activityChao-Yuan Xiao, Zhi-You Hao, Meng Yang, et al.
Frontiers in Medicine|January 24, 2024
Knowledge and awareness of nicotine, nicotine replacement therapy, and electronic cigarettes among general practitioners with a special interest in respiratory medicine in ChinaQian Zhong, Kang An, Zengxiang Wu, et al.
Annals of Palliative Medicine|October 21, 2021
Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitorsLu-Shan Xiao, Qi-Mei Li, Cheng-Yi Hu, et al.
BMC Cancer|July 6, 2022
Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort studyLu-Shan Xiao, Rui-Ning Li, Hao Cui, et al.
Cancer Medicine|May 23, 2022
Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitorsLu-Shan Xiao, Cheng-Yi Hu, Hao Cui, et al.
Hua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology|September 28, 2007
[Initial study on discrimination of oral microorganisms with the metabonomics technique]Miao Li, Li-ying Xiao, Ji-yao Li, et al.
Journal of Neurotrauma|November 10, 2016
Leukemia Inhibitory Factor Contributes to Reactive Astrogliosis via Activation of Signal Transducer and Activator of Transcription 3 Signaling after Intracerebral Hemorrhage in RatsHua-Jun Zhou, Xi Yang, Han-Jin Cui, et al.
Die Pharmazie|March 20, 2014
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activityWen-Wen Li, Guo-Xian Long, Dong-Bo Liu, et al.
Pageof 25

Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Journal for Immunotherapy of Cancer|March 10, 2022
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world studyQi Mei, Guangyuan Hu, Yang Yang, et al.
Frontiers in Cell and Developmental Biology|July 21, 2022
Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach AdenocarcinomaNa Luo, Min Fu, Yiling Zhang, et al.
Fitoterapia|October 17, 2025
Five new lanostane-type triterpenoids from Poria cocos and their in vitro anti-asthmatic activityChao-Yuan Xiao, Zhi-You Hao, Meng Yang, et al.
Frontiers in Medicine|January 24, 2024
Knowledge and awareness of nicotine, nicotine replacement therapy, and electronic cigarettes among general practitioners with a special interest in respiratory medicine in ChinaQian Zhong, Kang An, Zengxiang Wu, et al.
Annals of Palliative Medicine|October 21, 2021
Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitorsLu-Shan Xiao, Qi-Mei Li, Cheng-Yi Hu, et al.
BMC Cancer|July 6, 2022
Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort studyLu-Shan Xiao, Rui-Ning Li, Hao Cui, et al.
Cancer Medicine|May 23, 2022
Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitorsLu-Shan Xiao, Cheng-Yi Hu, Hao Cui, et al.
Hua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology|September 28, 2007
[Initial study on discrimination of oral microorganisms with the metabonomics technique]Miao Li, Li-ying Xiao, Ji-yao Li, et al.
Journal of Neurotrauma|November 10, 2016
Leukemia Inhibitory Factor Contributes to Reactive Astrogliosis via Activation of Signal Transducer and Activator of Transcription 3 Signaling after Intracerebral Hemorrhage in RatsHua-Jun Zhou, Xi Yang, Han-Jin Cui, et al.
Die Pharmazie|March 20, 2014
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activityWen-Wen Li, Guo-Xian Long, Dong-Bo Liu, et al.
Pageof 25